by Lavang Vu
Reemergence
of Men's Inhibitor Support
A
s a person with a rare bleeding disorder, I don't get many chances to meet fellow blood brothers that live all over the country. Myself, and others alike, need programs like the hemophilia conferences. There are conferences for every field that you can imagine. These conferences are very important and are integral parts of the scientific community. Most people do not realize that the scientific community also includes the patients, whether they are rare or not. As exceptional as the conferences are, the experiences of inhibitor patients are vastly different from those who do not have an inhibitor. We need completely different medications and face a unique set of challenges. For example, a patient with mild hemophilia may lead a more relatively normal life due to more stable factor levels. And in turn, he or she may experience fewer bleeds in a lifetime. Inhibitor patients, on the other hand, experience significantly challenging, more frequent bleeding
5 n LIFELINES for HEALTH n Fall/Winter 2022
symptoms. I used to get an ankle bleed once every two weeks or so seemingly out of nowhere at times. To learn more about these challenges and advances in the field, Momentum was created several years ago as a program for individuals with an inhibitor to come together and learn from the amazing speakers, as well as each other. There is a problem in the inhibitor community. The resources once available have dried up since the devastation of the pandemic. We no longer have the inhibitor summits from NHF or any similar conferences. CHES is the only group in the entire United States that provides conferences specifically for inhibitor patients. It all really started with the inhibitor family camps back in 2010 from which I had the pleasure. CHES has been supporting the inhibitor community for a very long time. And today, seems to be the only provider of insights into the advances in treatment and care for inhibitor patients.